Natural history of inherited retinal diseases
Official title: Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients
Run by Augelux Therapeutics · NCT07085533 · Data updated 2026-11-12
This project will test whether color vision problems relate to retinal structure and visual function in people with inherited retinal dystrophies and in people without retinal disease.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Augelux Therapeutics Industry-sponsored |
| Locations | 1 site (Wuhan) |
| Status | Recruiting |
| Started | July 20, 2025 |
| Main results expected | June 4, 2027 |
| Study ends | September 28, 2027 |
| Registry record updated | December 10, 2025 |
| Trial ID | NCT07085533 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with a confirmed diagnosis of an inherited retinal dystrophy who can identify and describe colors and communicate during testing, along with control participants who have no retinal disease and normal color vision.
✕Probably not a fit
Patients whose color vision loss is due to non‑retinal causes (for example optic neuropathy) or who cannot reliably perform color testing because of cognitive or communication limitations are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study will enroll about 200 participants, including a heterogeneous group of patients with inherited retinal dystrophies (across genotypes and severities) and control participants without retinal disease. All participants will complete a standardized battery including quantitative color vision testing, best-corrected visual acuity (BCVA), and advanced multimodal retinal imaging such as spectral-domain OCT to measure ellipsoid zone (EZ) integrity and retinal thickness. The study will integrate imaging metrics with clinical and genotypic data to characterize relationships between color discrimination deficits and outer retinal microstructure. The principal focus is on linking impairments in color vision to morphological disruptions of the EZ and other retinal biomarkers.
Why it matters
Potential benefit: If successful, this work could help clinicians use color vision tests and retinal imaging to better predict visual function and to inform patient selection and outcome measures for future therapies.
How similar studies have gone: Previous work, particularly in retinitis pigmentosa cohorts, has shown correlations between ellipsoid zone integrity and chromatic discrimination, so this protocol builds on existing evidence rather than being wholly novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Color Perception and Communication Ability Participants must have the ability to verbally identify or describe colors and test stimuli. This requires adequate cognitive and communicative capacity to understand instructions and respond appropriately during color vision testing. 2. Diagnosis of Inherited Retinal Dystrophy (IRD Group Only) Participants assigned to the IRD group must have a confirmed clinical diagnosis of an inherited retinal dystrophy 3. No Evidence of Inherited Retinal Disease (Control Group Only) Participants in the control group must have: * No known history or clinical evidence of inherited retinal degeneration * Normal retinal health or only non-retinal ocular conditions not affecting retinal function (e.g., mild cataract, corrected refractive error) * Normal or expected-normal color vision Exclusion Criteria: 1. Non retinal causes of color vision loss * Optic neuropathies (e.g., optic neuritis, glaucoma related optic nerve damage) * Cortical vision impairments affecting color perception * Any other neurological or optic nerve pathology causing color vision deficiency 2. Psychological or cognitive conditions affecting color perception or communication * Severe developmental delays * Cognitive impairments interfering with ability to comprehend or reliably perform color vision tests * Psychiatric conditions that impair visual interpretation or reliable testing 3. Prior treatment with potential transient effects on the retina * Recent retinal surgery * Recent drug therapy affecting retinal structure or function * Any acute intervention that might confound the correlation analyses due to lack of a stable baseline
Where it's running
-
Renmin Hospital of Wuhan University
Wuhan, China Recruiting
Study contacts
- Principal investigator: Yin Shen — Renmin Hospital of Wuhan University
- Study coordinator: Wenhui Zhou
- Email: mojtaba98shirinzadeh@gmail.com
- Phone: +86 15527905531
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Linking genetic changes to symptoms in Egyptian children with congenital muscle disorders
This project will test whether specific genetic changes explain symptoms in Egyptian children under 18 who have congenital myopathies or congenital muscular dystrophies.
-
Examining the genetic traits of hereditary xerocytosis
This study is trying to find out more about hereditary xerocytosis by looking at the genes involved and how they affect people with this blood condition.
-
Wavefront-Guided LASIK with a 10 MHz Elita Laser in Myopic Eyes
This study tests whether using a 10 MHz Elita femtosecond laser for wavefront-guided LASIK in people with myopia or myopic astigmatism can achieve 6–12 month outcomes comparable to or better than prior myopic LASIK results.
-
Noninvasive imaging biomarkers to see if ophthalmic artery narrowing relates to geographic atrophy in age-related macular degeneration
This study tests whether narrowed ophthalmic artery vessels are linked to the development or worsening of geographic atrophy in people with dry age-related macular degeneration.
-
Comparison of ACUVUE OASYS MAX 1-Day Multifocal vs DAILIES AquaComfort Plus Multifocal
This study tests two daily multifocal contact lenses in adults 40–70 to see which provides better vision and comfort while wearing them regularly.
-
Multimodal-feedback vision rehabilitation for people with central vision loss
This trial will test whether five weekly sessions of binocular multimodal feedback training can improve eye movement control in people with bilateral central vision loss from macular degeneration.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.